TrialCancer research communications2026

Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).

Emily K Ninmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.